Act Wealth Management, LLC Edwards Lifesciences Corp Transaction History

Act Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$84.3 - $94.31 $8,430 - $9,431	-100 Reduced 3.31%	2,920 $269,000
Q2 2023 Jul 14, 2023	SELL	$81.41 - $94.33 $6,512 - $7,546	-80 Reduced 2.58%	3,020 $284,000
Q1 2022 Apr 12, 2022	SELL	$101.96 - $128.34 $20,392 - $25,668	-200 Reduced 6.06%	3,100 $365,000
Q4 2021 Jan 31, 2022	BUY	$106.37 - $130.68 $351,021 - $431,244	3,300 New	3,300 $428,000
Q3 2021 Oct 12, 2021	SELL	$102.91 - $122.75 $339,603 - $405,075	-3,300 Closed	0 $0
Q1 2021 Apr 08, 2021	BUY	$78.68 - $90.67 $259,644 - $299,211	3,300 New	3,300 $276,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Act Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Act Wealth Management, LLC with notifications on news.